Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AE58054 add-on to donepezil in moderate Alzheimer's disease
2009-011845-24Phase 2Completed
- Sponsor
- Lundbeck
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Lu AE58054 + donepezil with Placebo + donepezil (2 arms). Primary endpoint: Change from baseline in Alzheimer's Disease Assessment Scale-cognitive subscale. Started Jul 2009; status: completed.
02
Drugs
Idalopirdine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2009-011845-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011845-24.